👉Haller is the first patient to receive the shot in the study.
Patient Jennifer Haller is given the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16.
The study is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, Washington.
Testing will begin with 45 young, healthy volunteers with different doses of shots.
There’s no chance participants could get infected from the shots, because they don’t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.
https://www.facebook.com/voiceofamerica/videos/643656029822988/
Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they’re pursuing different types of vaccines — shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent.
